The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists

Assistance Publique - Hôpitaux de Paris

Overview

The RATIO registry is a French registry designed by a multidisciplinary group to collect data on opportunistic and severe bacterial infections and lymphoma in patients treated with TNF-a antagonists ( infliximab, etanercept and adalimumab). A total of 486 medical units in metropolitan France participate in the RATIO registry. All diagnosis are retained after validation by 2 qualified infectious disease or haematologist physicians (on the basis of the standardized case report form, the hospitalisation summary, and the microbiological and radiological results). Risk factors for developing these conditions when treated by TNF-a antagonists will be identified in a case control study. Incidence of these diseases will be calculated.

Study Type

OBSERVATIONAL

Conditions

Rheumatoid Arthritis Crohn's Disease Ankylosing Spondylitis Psoriasis

Interventions

TNF-alpha antagonistsDRUG

Eligibility

Sex: ALLMin age: 0 Years

Medical Language ↔ Plain English

Inclusion Criteria for cases: * past or current treatement with TNF-a antagonists * either lymphoma severe bacterial infection opportunistic infection Inclusion Criteria for controls: * matched with cases by gender, age (+/- 5 years), underlying disease (rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, or psoriasis) * past or current treatement with TNF-a antagonists * no lymphoma, severe bacterial infection, opportunistic infection (same as case) Exclusion Criteria: * none

Locations (1)

All French departments of rheumatology, internal medicine, gastro-enterology, dermatology, infectious diseases, intensive care unit, oncology and haematology, paediatrics and chest medicine

All Cities, France

RECRUITING

Central Contacts

Florence TUBACH, MD

CONTACT

01 40 25 62 51 florence.tubach@bch.aphp.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.